Brain Tumor, Primary, Craniotomy, Supratentorial Neoplasms
Conditions
Keywords
fluid therapy, neurosurgery
Brief summary
Fluid management during neurosurgery presents a special clinical agenda. Volume overload can have detrimental effects on intracranial pressure by increasing either cerebral blood volume or hydrostatically driven cerebral edema formation. On the other hand, an overt restrictive fluid strategy may risk hemodynamic instability. Recently, dynamic fluid responsiveness parameters such as stroke volume variation (SVV) have been shown as a more precise parameters for fluid management including in neurosurgical patients. The threshold of SVV is reported about 10-15%. In this study, the investigators aim to using two SVV threshold to conduct intraoperative fluid therapy for craniotomy. Randomization will be generated by computer sampling. One of the two groups of patients will be managed with fluid bolus to keep intraoperative SVV \<10% presenting the normovolemia group. The other group of patients will be kept intraoperative SVV \<18% which is slightly above previously reported SVV threshold upper limit. The second group thus presents the restrictive group. Clinical outcomes, laboratory analysis including S100-B for neuronal damage and neutrophil gelatinase-associated lipocalin (NGAL) for acute kidney injury, will be compared.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Supratentorial brain tumor receiving elective craniotomy * BMI between 18.5-27.0 kg.m-2
Exclusion criteria
* Cardiac dysfunction, such as coronary artery diseases; atrial fibrillation; * NYHA class II * Renal dysfunction, eGFR\< 60 ml.min-1.1.73m-2 * Pulmonary cormorbidity, such as COPD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum S100B protein | Changes from preoperative to postoperative day 2 |
| serum NGAL level | Changes from preoperative to postoperative day 2. |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospital stay | participants will be followed for the duration of hospital stay, an expected average of 3 to 4 weeks |
| Postoperative complications rate | participants will be followed for the duration of hospital stay, an expected average of 3 to 4 weeks |
| Total intraoperative intravenous fluid administrated | During the surgical time, an expected average of 3 to 5 hours |
Countries
Taiwan